PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S.
Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14.
Plasmablastic lymphoma: An update.
Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ.
Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863.
Extranodal T- and NK-cell lymphomas.
de Leval L, Feldman AL, Pileri S, Nakamura S, Gaulard P.
Virchows Arch. 2023 Jan;482(1):245-264. doi: 10.1007/s00428-022-03434-0. Epub 2022 Nov 7.
Mantle cell lymphoma-Update on molecular biology, prognostication and treatment approaches.
Silkenstedt E, Dreyling M.
Hematol Oncol. 2023 Jun;41 Suppl 1:36-42. doi: 10.1002/hon.3149.
Optimizing treatment of HIV-associated lymphoma.
Noy A.
Blood. 2019 Oct 24;134(17):1385-1394. doi: 10.1182/blood-2018-01-791400.
A single-cell atlas of diffuse large B cell lymphoma.
Ye X, Wang L, Nie M, Wang Y, Dong S, Ren W, Li G, Li ZM, Wu K, Pan-Hammarström Q.
Cell Rep. 2022 Apr 19;39(3):110713. doi: 10.1016/j.celrep.2022.110713.
Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
Ferry JA.
Oncologist. 2006 Apr;11(4):375-83. doi: 10.1634/theoncologist.11-4-375.
Senescence-associated reprogramming promotes cancer stemness.
Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, Dörken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, Schmitt CA.
Nature. 2018 Jan 4;553(7686):96-100. doi: 10.1038/nature25167. Epub 2017 Dec 20.
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P, Zhang M.
Clin Epigenetics. 2020 Nov 7;12(1):169. doi: 10.1186/s13148-020-00962-x.
Update on the therapy of highly aggressive non-Hodgkin's lymphoma.
Jacobsen E, LaCasce A.
Expert Opin Biol Ther. 2006 Jul;6(7):699-708. doi: 10.1517/14712598.6.7.699.
